Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma
2020 · Scientific Reports · 56 citations
https://doi.org/10.1038/s41598-020-73965-6
S
Sho Iwaki
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
130
Citations
5
h-index
3
i10-index
Sho Iwaki is an academic researcher from Nagoya City University. The author has contributed to research in topics: Head and Neck Cancer Studies & Cancer Immunotherapy and Biomarkers & Salivary Gland Tumors Diagnosis and Treatment. The author has an h-index of 5, co-authored 30 publications.
ORCID: 0000-0003-1808-6941Papers by this author
worksImpact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
2022 · Scientific Reports · 15 citations
https://doi.org/10.1038/s41598-022-18611-z
Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan
2024 · International Journal of Cancer · 8 citations
https://doi.org/10.1002/ijc.34972
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy
2025 · Oral Oncology · 7 citations
https://doi.org/10.1016/j.oraloncology.2025.107280
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat